Business

Prestige Brands

Advertisement

Prestige Brands Holdings Inc. rallied the most since its 2005 initial public offering. Genomma Lab Internacional made an unsolicited offer to buy all outstanding common shares of Prestige - an Irvington, N.Y.-based company that makes products such as Comet, Clear Eyes eye care products, and PediaCare - for $16.60 per share, valuing the company at $834 million. Prestige said it will review the offer.